Nachman Norwood & Parrott’s Precision BioSciences DTIL Stock Holding History

Nachman Norwood & Parrott’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1.86M	Sell	4,949 -237	-5%	-$71.2K	0.19%	89
2021 Q1	$1.61M	Buy	5,186 +11	+0.2%	+$3.85K	0.18%	93
2020 Q4	$1.29M	Buy	5,175 +11	+0.2%	+$2.7K	0.15%	98
2020 Q3	$954K	Buy	5,164 +392	+8%	+$78K	0.13%	108
2020 Q2	$1.19M	Buy	4,772 +21	+0.4%	+$4.6K	0.2%	93
2020 Q1	$860K	Sell	4,751 -89	-2%	-$23.3K	0.17%	91
2019 Q4	$2.02M	Buy	+4,840	New	+$1.52M	0.33%	65

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nachman Norwood & Parrott's DTIL Position: Q2 2021 in Review

Nachman Norwood & Parrott reduced its Precision BioSciences (DTIL) stake by 4.6% in Q2 2021, selling an estimated $71.2K and leaving 4,949 shares worth $1.86M. The position accounts for 0.19% of the portfolio, ranked #89.

Nachman Norwood & Parrott first reported a position in DTIL in Q4 2019 and has held it in 7 quarters since. The position peaked at $2.02M in Q4 2019. 130 funds tracked by Wall St. Rank hold DTIL as of Q2 2021.

Nachman Norwood & Parrott held 4,949 shares of Precision BioSciences worth $1.86M as of Q2 2021.
Nachman Norwood & Parrott sold 237 Precision BioSciences shares in Q2 2021, an estimated $71.2K.
Precision BioSciences made up 0.19% of Nachman Norwood & Parrott's portfolio in Q2 2021, its #89 holding.
Nachman Norwood & Parrott first reported a position in Precision BioSciences in Q4 2019 and has held it in 7 quarters since.
Nachman Norwood & Parrott's Precision BioSciences position peaked at $2.02M in Q4 2019.
130 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2021.

Based on Nachman Norwood & Parrott's 13F filing for Q2 2021, filed 13 Aug 2021.